# Clinicopathologic characteristics and outcomes of Chinese patients with non‐small‐cell lung cancer and <i><scp>BRAF</scp></i> mutation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinicopathologic-characteristics-and-outcomes-of-chinese-patients-with-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xi Ding,Zengli Zhang,Tao Jiang,Xuefei Li,Chao Zhao,Bo Su,Caicun Zhou |
| Citations | 62 |
| DOI | 10.1002/cam4.1014 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.1014 |
| OpenAlex ID | https://openalex.org/W2581875648 |
| PMID | 28135039 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Bo Su](https://scholariq.org/researchers/bo-su/)

## Paper journal

- [Cancer Medicine](https://scholariq.org/journals/cancer-medicine/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.